U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07437911) titled 'A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs' on Feb. 20.
Brief Summary: This study is a triple-blind, placebo-controlled, randomized controlled trial of 120 adults that will evaluate the impact of a novel nutritional supplement on improving nutrient gaps and changing nutrient status and the gut microbiome among glucagon-like peptide-1 receptor agonist (GLP-1 RA) users.
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Nutrition Intake
Nutrition Status
Gastrointestinal Microbiome
GLP-1
Intervent...